AzTrials
AzTrials

Acquired Brain InjuryNCT06510023

Rewards Sensitivity After Brain Injury

A study testing Type of reward presented in people with Acquired Brain Injury, run by Shirley Ryan AbilityLab at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A study measuring rewards sensitivity in individuals with acquired brain injury at an acute rehabilitation level. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Acquired Brain Injury
What is being tested?
Type of reward presented
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteUnited States
Study dates
21 Mar 2021to 20 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Individuals with ABI
  • Diagnosis of Traumatic Brain Injury or Stroke, based on their medical records
  • Age between 18-100
  • Able to follow directions in English (measured informally during screening)
  • Able to use at least one upper extremity (demonstrated by holding a pen)
  • Mild-moderate or lesser diagnosis in cognitive-communication area
Show all 13Show fewer
  • Score of 25 or higher on the Orientation Log assessment
  • Able to consent for participation in study (identifies through chart review)
  • Capable of understanding and cooperating with the experimental procedures.
  • Healthy participants
  • Age of 18 to 100 years old
  • Ability to follow directions in English
  • Ability to use at least one upper extremity.

Who cannot join

  • Individuals with ABI
  • Additional diagnosis of a neurological disorder other than ABI
  • Additional diagnosis of aphasia.
  • Having cognitive or behavioral impairments that preclude participation in the experimental procedures
  • Healthy Participants
  • history of significant cerebrovascular or neurological disease including (but not limited to) meningitis, epilepsy and/or seizures, stroke, tumor, multiple sclerosis, meningitis, mental retardation, dementia.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Shirley Ryan AbilityLab

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: Preserved Reward Sensitivity During Acute Rehabilitation Following Acquired Brain Injury

A study measuring rewards sensitivity in individuals with acquired brain injury at an acute rehabilitation level.

Read the detailed description

Individuals in acute rehabilitation following acquired brain injury journal (ABI) and aged-matched, non-injured controls will be recruited for this study.

Testing sessions will take place in a private treatment room at the Shirley Ryan AbilityLab and required 45 minutes to complete. Upon entering the room, participants will be greeted, electrodes placed on the participant's fingers to record their electrodermal activity, and participants will provide demographic information. Participants will then be instructed about how to respond on the Cued Reinforcement Response Time task (CRRT, see description below), and complete the task on a laptop computer while their electrodermal activity is being recorded. In this task, they are instructed to respond as quickly and accurately as possible, and will be informed that they will receive a monetary reward based on their accuracy at the completion of the task. Finally, participants will complete 3 self-report measures: (1) explicit level of motivation was measured in a post-study survey which included two items from the Sensitivity to Punishment and Sensitivity to Reward Questionnaire, (SPSRQ); (2) Reward sensitivity was evaluated using the Reward Responsiveness Scale , and (3) depression was evaluated using the Patient Health Questionnaire (PHQ-8) survey. At the end of the session, the electrodes will be removed, and participants will be debriefed and provided their monetary reward

Being tested
Type of reward presented
Keywords
Rewards Sensitivity, Motivation, Acquired Brain Injury, Electrodermal Activity
Medical subject headings
Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Type of reward presentedBehavioural

    Three different types of rewards were presented to both groups during the computerized task: one dollar, one penny, and no reward.

Study groups in NCT06510023
Study groupRoleWhat they receive
Individuals with Acquired Brain InjuryExperimentalMeasuring the effect of three different types of rewards (one dollar, one penny, and no reward) on performance in a cognitive test.
Receives: Behavioral: Type of reward presented
Non-impaired controlsOtherMeasuring the effect of three different types of rewards (one dollar, one penny, and no reward) on performance in a cognitive test.
Receives: Behavioral: Type of reward presented

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance on a Cued Response Reaction Time Task, in each of the three rewards conditions (Dollar, Penny, No reward)

    Accuracy (percentage of correct responses) in a Cued Response Reaction task

    Measured: 15 minutes

  2. Performance on a Cued Response Reaction Time Task, in each of the three rewards conditions (Dollar, Penny, No reward)

    Response time (time in milliseconds) in a Cued Response Reaction task

    Measured: 15 minutes

  3. Electrodermal activity (EDA) before, during and after the Cued Response Reaction task

    Number of skin conductance responses (SCRs) before, during and after the task

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2024
  2. Study start21 Mar 2021
  3. Primary completion20 Mar 2022
  4. Study completion20 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Factorial
Model description
2X3 non-randomized, within-participant design.
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06510023
Sponsor's protocol ID
STU00213877
Status last verified
Jul 2024
First submitted
11 Jul 2024
Last updated
19 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Type of reward presented in people with Acquired Brain Injury, run by Shirley Ryan AbilityLab at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance on a Cued Response Reaction Time Task, in each of the three rewards conditions (Dollar, Penny, No reward) (time frame: 15 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in